Pharmacological Effort and Medication Approaches for the Management of COVID-19 Pandemic in Nepal .
DOI:
https://doi.org/10.55530/ijmbiosnepal.v5i2.38Keywords:
COVID-19, Nepal, pharmacological efforts, vaccinesAbstract
COVID-19 pandemic has created a long-lasting effect on different aspects of peoples' life. Several efforts were made by Nepal for the management of the COVID-19 surge. This study intended to compile the pharmacological efforts adopted for the prevention and management of COVID-19 during its pandemic in Nepal. A comprehensive study was performed from 10th May to 25th May 2021. Altogether, 25 documents, three guidelines, and 30 articles were assessed and analysed in this study. The major pharmacological steps for the prevention of COVID-19 were seen through vaccination campaigns, the development of guidelines, and the use of repurposed drugs (Remdesivir, corticosteroids, anticoagulants etc). Significant pharmacological steps were seen in the prevention and treatment of COVID-19 in Nepal during the pandemic. With the limited resources, Nepal’s action against COVID-19 seemed to be impressive; however, more efforts are demanded to combat similar situations in the future.
References
Kim MS, An MH, Kim WJ, Hwang T-H. Comparative efficacy and safety of pharmacological interventions for the treatment of COVID-19: A systematic review and network meta-analysis. PLoS medicine. 2020;17(12):e1003501.https://doi.org/10.1371/journal.pmed.1003501. PMid:33378357 PMCid:PMC7794037
Shrestha R, Shrestha S, Khanal P, Kc B. Nepal's first case of COVID-19 and public health response. Journal of Travel Medicine. 2020 Apr;27. https://doi.org/10.1093/jtm/taaa024. PMid:32104884 PMCid:PMC7107523
Dhakal N, Poudyal A, Gyanwali P. Pharmacological Treatment for the Management of COVID-19: A Narrative Review. JNMA: Journal of the Nepal Medical Association. 2021 Jun;59(238):614. https://doi.org/10.31729/jnma.5920. PMid:34508415
Piryani RM, Piryani S, Shah JN. Nepal's response to contain COVID-19 infection. Journal of Nepal Health Research Council. 2020;18(1):128. https://doi.org/10.33314/jnhrc.v18i1.2608. PMid:32335608
Poudel A. Nepal begins first phase of Covid-19 vaccination drive. The Kathmandu Post. 2021.https://kathmandupost.com/health/2021/01/27/nepal-begins-first-phase-of-vaccination-drive-against-covid-19
Department of Drug Administration. EUA (Emergency Use Authorization) for SPUTNIK-V - COVID-19 Vaccine. 2021. https://www.dda.gov.np/events/eua-emergency-use-authorization-for-sputnik-v-covid-19-vaccine
Department of Drug Administration. EUA of covid 19 vaccine (Vero cell), inactivated manufactured by BIBP(under Sinopharm). 2021. https://www.dda.gov.np/events/eua-of-covid-19-vaccine-vero-cell-inactivated-manufactured-by-bibp-under-sinopharm
World Health Organization. Situation Update #54- Coronavirus Disease 2019 (COVID-19) WHO Country Office for Nepal. 2021. https://cdn.who.int/media/docs/default-source/nepal-documents/novel-coronavirus/who-nepal-sitrep/-54_weekly-who-nepal-situation-updates.pdf?sfvrsn=6292929d_5
Nepal's vaccination status. Available from: https://kathmandupost.com/health/2021/12/06/all-you-need-to-know-about-nepal-s-vaccination-status-1638759390
World Health Organization. COVID-19 Vaccine ChAdOx1-S [recombinant] Developed by Oxford University and AstraZeneca 2021 .
World Health Organization. WHO lists additional COVID-19 vaccine for emergency use and issues interim policy recommendations. https://www.who.int/news/item/07-05-2021-who-lists-additional-covid-19-vaccine-for-emergency-use-and-issues-interim-policy-recommendations
Logunov DY, Dolzhikova IV, Shcheblyakov DV, Tukhvatulin AI, Zubkova OV, Dzharullaeva AS, et al. Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia. The Lancet (British edition). 2021;397(10275):671-81.
Nepal Medical Council. INTERIM CLINICAL GUIDANCE FOR CARE OF PATIENTS WITH COVID-19 IN HEALTHCARE SETTINGS. Kathmandu 2020.
Nepal Medical Council. Clinical Guidance for COVID-19 - Update 2 2020. Available from : https://nmc.org.np/files/4/NMC%20Clinical%20Guidance%20Update%20%202_Oct_21_2020.pdf
Department of Drug Administration, 2020. Available from: https://www.dda.gov.np/
World Health Organization. WHO recommends against the use of remdesivir in COVID-19 patients.2020.https://www.who.int/news-room/feature-stories/detail/who-recommends-against-the-use-of-remdesivir-in-covid-19-patients
Department of Ayurveda and Alternative Medicine, Nepal Ayurvedic Medical Council, Ayurveda Campus, and Teaching Hospital. Ayurveda and Alternative Medicine Guidelines of Preventive Measures and Management Protocol for COVID 19 in Nepal 2020. Available from: https://doaa.gov.np/wp-content/uploads/2020/05/Protocol-DOAA-AAM-COVID19-1-1.pdf
Ministry of Health and Population Nepal. 2021; Available from : https://www.mohp.gov.np/eng/
Bhattarai S, Dhungana J. A million-dose success for Nepal: insights from Nepal's national vaccine deployment plan against COVID-19. Journal of travel medicine. 2021. https://doi.org/10.1093/jtm/taab027. PMid:33668060 PMCid:PMC7989250
Ritchie H, Ortiz-Ospina E, Beltekian D, Mathieu E, Hasell J, Macdonald B, et al. Coronavirus (COVID-19) Vaccinations. 2021.
GAVI. The COVID-19 vaccine race.2021.Available from: https://www.gavi.org/vaccineswork/covid-19-vaccine-race 22. Centers for Disease Control and Prevention. Covid Data Tracker. 2021. Available from : https://covid.cdc.gov/covid-data-tracker/#datatracker-home
World Health Organization. WHO recommends against the use of remdesivir in COVID-19 patients.2020.https://www.who.int/news-room/feature-stories/detail/who-recommends-against-the-use-of-remdesivir-in-covid-19-patients
Nepal Medical Council. INTERIM CLINICAL GUIDANCE FOR CARE OF PATIENTS WITH COVID-19 IN HEALTHCARE SETTINGS. Kathmandu 2020. https://nmc.org.np/interim-clinical-guidance-for-care-of-patients-with-covid-19-in-healthcare-settings-1
Nepal Health Research Council. Compassionate Use of Remdesivir and Convalescent Plasma Therapy for the Treatment of Covid-19 Infection in Nepal: A Prospective Observational Study 2020.http://nhrc.gov.np/publication/compassionate-use-of-remdesivir-and-convalescent-plasma-therapy-for-the-treatment-of-covid-19-infection-in-nepal-a-prospective-observational-study/
Beigel JH, Tomashek KM, Dodd LE, Mehta AK, Zingman BS, Kalil AC, et al. Remdesivir for the treatment of Covid-19. New England Journal of Medicine. 2020;383(19):1813-26. https://doi.org/10.1056/NEJMoa2007764. PMid:32445440 PMCid:PMC7262788
Health NIo. Coronavirus disease 2019 (COVID-19) treatment guidelines. NIH: Bethesda, MD, USA. 2020. https://www.covid19treatmentguidelines.nih.gov/
Group RC. Dexamethasone in hospitalized patients with Covid-19. New England Journal of Medicine. 2021;384(8):693-704.https://doi.org/10.1056/NEJMoa2021436. PMid:32678530 PMCid:PMC7383595
Nepal Medical Council. COVID Management Annex. 2021.Available from : https://nmc.org.np/files/4/2078.01.29%20COVID%20mgmt%20Annex.pdf
Department of Drug administration, Biratnagar, 2021.Available from: https://www.dda.gov.np/content/biratnagar
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Neelam Dhakal, Selina Siwakoti, Urmila Shakya, Astha Acharya, Dr. Pradip Gyanwali
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
IJMBioS follows the following Terms and License of the manuscript under Attribution-NonCommercial 4.0 International (CC BY-NC 4.0) where Author and Journal are can Share — copy and redistribute the material in any medium or format and Adapt — remix, transform, and build upon the material, and it is Non-Commercial.
